Kui Dong

Learn More
AIM To investigate whether the transfer of the IL-37b gene, a newly identified inhibitor of both innate and adaptive immunity, could improve the therapeutic efficacy of mesenchumal stromal cells (MSCs) in inflammatory bowel disease (IBD). METHODS The expression of IL-37 in biopsied specimens of the patients with active ulcerative colitis (UC) was detected(More)
  • 1